FIELD: medicine. SUBSTANCE: present invention describes compounds of formula (I): 
wherein W, Ar1, Ar2 and Ar3 are as defined in the specification and pharmaceutically acceptable salts of said compounds. These compounds are agent P antagonists and are useful for treatment of intestinal disorders, inflammatory diseases and central nervous system disorders, and pains. EFFECT: improved properties. 25 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SYNERGETIC TREATMENT OF PARKINSONISM | 1995 |
|
RU2176145C2 |
| 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5-HT3 MODULATORS | 2007 |
|
RU2448105C2 |
| SUBSTITUTED 3-AZABICYCLO[3_1_0]HEXANES AS KETOHEXOKINASE INHIBITORS | 2016 |
|
RU2696269C1 |
| DERIVATIVES OF CYCLOHEXANE OR TETRAHYDROPYRANE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, OR HYDRATES, OR SOLVATES OF THESE COMPOUNDS, OR THEIR SALTS, INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS AND FUNGICIDE AGENT | 1992 |
|
RU2084439C1 |
| NITRILE-CONTAINING ANTIVIRAL COMPOUNDS | 2021 |
|
RU2820150C2 |
| CONDENSED SUBSTITUTED AMINOPYRROLIDINE DERIVATIVE | 2007 |
|
RU2443698C2 |
| METHOD OF TREATMENT OR PROPHYLAXIS OF MAMMALS AND HUMAN WITH VOMITING USING SOME QUINUCLIDINE, PIPERIDINE, AZANORBORNANE, ETHYLENEDIAMINE DERIVATIVES AND RELATED COMPOUNDS | 1994 |
|
RU2135179C1 |
| METHOD OF PREPARING N-HYDROXYUREA, N-HYDROXYUREA DERIVATIVES AND METHOD OF INHIBITING LIPOXYGENASE IN MAMMALS | 1991 |
|
RU2104267C1 |
| 3R,4S 3-[4-(4-FLUOROPHENYL)-4-HYDROXYPIPERIDIN-1- YL)CHROHAN-4,7-DIOL, OPTICAL ISOMERS THEREOF AND PHARMACEUTICAL COMPOSITION BASED THEREON, AND METHOD OF MEDICAL TREATMENT | 1994 |
|
RU2126404C1 |
| HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF 5-LIPOXYGENASE ACTIVITY | 1995 |
|
RU2136666C1 |
